Civic Intelligence

Vanguard Urologic Research Foundation

990 • Fiscal year 2016 • EIN 20-5972989

Jan 01, 2016 to Dec 31, 2016 • Filed on Nov 14, 2017

Organization Profilen/a
6400 FANNIN ST No 2300Houston, TX 77030

(713) 366-7848

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

78th percentile

0.12x

Higher debt load relative to assets than 78% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Liabilities / Revenue

65th percentile

0.01x

Higher debt load relative to revenue than 65% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Net Margin

87th percentile

36%

Higher net margin than 87% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Top Officer Pay

75th percentile

$0

Higher top officer pay than 75% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Asset Growth

87th percentile

61%

Faster asset growth than 87% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Annualized from 2015 to 2016

Revenue Growth

36th percentile

-8.4%

Faster revenue growth than 36% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Annualized from 2015 to 2016

Balance Sheet
Liabilities / Assets78th percentile

Assets

Up

$2,265

Up $856 (+61%) from 2015

Net Assets

Up

$1,998

Up $8,023 (+133%) from 2015

Liabilities

Down

$267

Down $7,167 (-96%) from 2015

Revenue And Expenses
Liabilities / Revenue65th percentileNet Margin87th percentile

Revenue

Down

$22,006

Down $2,007 (-8.4%) from 2015

Expenses

Down

$13,984

Down $28,917 (-67%) from 2015

Net Income

Up

$8,022

Up $26,910 (+142%) from 2015

Historical Trend

Balance Sheet Trend

Asset Growth87th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200K$100K$0-$100KAssets 2010: $114,871Liabilities 2010: $15,279Net Assets 2010: $99,5922010Assets 2011: $64,949Liabilities 2011: $8,492Net Assets 2011: $56,4572011Assets 2012: $92,725Liabilities 2012: $180,655Net Assets 2012: -$87,9302012Assets 2013: $4,484Liabilities 2013: $0Net Assets 2013: $4,4842013Assets 2014: $13,196Liabilities 2014: $333Net Assets 2014: $12,8632014Assets 2015: $1,409Liabilities 2015: $7,434Net Assets 2015: -$6,0252015Assets 2016: $2,265Liabilities 2016: $267Net Assets 2016: $1,9982016Assets 2017: $28,490Liabilities 2017: $899Net Assets 2017: $27,5912017Assets 2018: $0Liabilities 2018: $0Net Assets 2018: $02018

Highlighted filing

2016

Assets$2,265
Liabilities$267
Net Assets$1,998
Open 2016 Filing

Operations Trend

Revenue Growth36th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2010: $671,720Expenses 2010: $651,375Net Income 2010: $20,3452010Revenue 2011: $860,736Expenses 2011: $903,871Net Income 2011: -$43,1352011Revenue 2012: $427,570Expenses 2012: $571,957Net Income 2012: -$144,3872012Revenue 2013: $285,533Expenses 2013: $193,120Net Income 2013: $92,4132013Revenue 2014: $74,093Expenses 2014: $65,714Net Income 2014: $8,3792014Revenue 2015: $24,013Expenses 2015: $42,901Net Income 2015: -$18,8882015Revenue 2016: $22,006Expenses 2016: $13,984Net Income 2016: $8,0222016Revenue 2017: $35,015Expenses 2017: $9,421Net Income 2017: $25,5942017Revenue 2018: $20Expenses 2018: $27,611Net Income 2018: -$27,5912018

Highlighted filing

2016

Revenue$22,006
Expenses$13,984
Net Income$8,022
Open 2016 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Nov 14, 2017
Return Version
2016v3.0
Gross Receipts
$22,006
Mission and Program Overview

Mission

To establish the premier translation research program focused on prostate disease including prostate cancer and related diseases of the aging process.

Continuous and active conduct of medical research initially in conjunction with memorial hermann hospital.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$1,409$2,265▲ $856
Land, Buildings, and Equipment, Net$0$0→ $0
Total Assets$1,409$2,265▲ $856
Liabilities
Accounts Payable and Accrued Expenses$7,434$267▼ $7,167
Total Liabilities$7,434$267▼ $7,167
Net Assets / Fund Balance
Unrestricted Net Assets$-6,025$1,998▲ $8,023
Total Net Assets Fund Balance$-6,025$1,998▲ $8,023
Total Liabilities and Net Assets / Fund Balance$1,409$2,265▲ $856

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$0$14,957$14,957
Compensation and Service Providers
Top Officer Pay75th percentile

Board Members and Trustees

NameTitle
Kevin M Slawin MdPresident
Phil Weinstein MdDirector
Tom FarrellDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$22,000
Program Service Revenue
$0
Investment Income
$6
Other Revenue
$0
All Other Contributions
$22,000
Change in Net Assets
$8,022
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$13,984
Total Fundraising Expense$1,500
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Information Technology-$2,231-$2,231
Other Expenses$4,500$1,697$1,500$1,500
Office Expenses-$531-$531
Interest-$441-$441
Total Functional Expenses$4,500$7,984$1,500$13,984
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, line 11B

“Copies of form 990 are reviewed by the president and directors before filing.”

Form 990, Part VI, Section C, line 18

“Upon request copies all applicable documents are furnished. Organization is developing a website which will include these documents.”

Form 990, Part VI, Section C, line 19

“Governing docuemnts, conflict of interest policy and financial statements are furnished upon request.”

Filing and Contact Details

Filer

Filer Name
Vanguard Urologic Research Foundation
EIN
20-5972989
Phone
7133667848
Address
6400 FANNIN ST No 2300, HOUSTON, TX 77030

Signing Officer

Name
Kevin Slawin
Title
President
Phone
7132991776
Signed
2017-11-14

Organization Details

Principal Officer
Kevin Slawin
Formed
2006
Legal Domicile
TX
Voting Board Members
3
Independent Board Members
2
Employees
0
Volunteers
0

Preparer

Firm
Spain Price Reader & Thompson Pc
Address
2727 ALLEN PARKWAY SUITE 1850, HOUSTON, TX 77019
Preparer
Ronald L Price
Phone
7135201850
Supplemental Narrative

Additional Explanations

Form 990, Part XI, line 9:

“ROUNDING 1.”

Raw XML Appendix295 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt07434
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0267
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0CONTINUOUS AND ACTIVE CONDUCT OF MEDICAL RESEARCH INITIALLY IN CONJUNCTION WITH MEMORIAL HERMANN HOSPITAL.
IRS990/AllOtherContributionsAmt022000
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0KEVIN SLAWIN
IRS990/BooksInCareOfDetail/PhoneNum07133667848
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt06400 FANNIN ST SUITE 2300
IRS990/BooksInCareOfDetail/USAddress/CityNm0HOUSTON
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0TX
IRS990/BooksInCareOfDetail/USAddress/ZIPCd077030
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt01409
IRS990/CashNonInterestBearingGrp/EOYAmt02265
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd00
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt022000
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt06
IRS990/CYOtherExpensesAmt013984
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt08022
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt013984
IRS990/CYTotalFundraisingExpenseAmt01500
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt022006
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0Clinical Research and Community Health Promotion of the FDA-Approved Prostate Health Index (pHI ) test: In 2012, The pHI test, based on a novel, clipped form of prostate specific antigen (PSA) co-discovered by Dr. Slawin, was FDA-approved to detect prostate cancer in men with a PSA between 4 and 10 NG/ML. In 2014, the Vanguard Urologic Institute was the first in the nation to offer the PHI test in the Unites States. The PHI test addresses many of the concerns raised by the USPSTF regarding the PSA test, raising the prospects of reducing false negative tests, unnecessary biopsies and increasing the detection of high risk, life-threatening prostate cancer. Since then VURF has begun several initiatives involving the Phi test to evaluate its performance and to increase awareness and use of the test by physicians and patients. VURF via its clinical data and specimen bank is developing a large database of patients who have had the test done, along with another novel molecular test for prostate cancer screening, the urine PCA-3 test the includes clinical data and prostate biopsy results that will serve as the basis of scientific studies of the phi test in clinical practice . Furthermore, VURF is developing multiple resources, including mailing campaigns, websites and other activities to help educate physicians and patients about the phi test and its potential benefits to public health.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt04500
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt00.30
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt18.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt20.30
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0PHIL WEINSTEIN MD
IRS990/Form990PartVIISectionAGrp/PersonNm1KEVIN M SLAWIN MD
IRS990/Form990PartVIISectionAGrp/PersonNm2TOM FARRELL
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02006
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantAmt00
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt022006
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt02
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt02231
IRS990/InformationTechnologyGrp/TotalAmt02231
IRS990/InterestGrp/ManagementAndGeneralAmt0441
IRS990/InterestGrp/TotalAmt0441
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt06
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt06
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt014957
IRS990/LandBldgEquipBasisNetGrp/BOYAmt00
IRS990/LandBldgEquipBasisNetGrp/EOYAmt00
IRS990/LandBldgEquipCostOrOtherBssAmt014957
IRS990/LegalDomicileStateCd0TX
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TO ESTABLISH THE PREMIER TRANSLATION RESEARCH PROGRAM FOCUSED ON PROSTATE DISEASE INCLUDING PROSTATE CANCER AND RELATED DISEASES OF THE AGING PROCESS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt0-6025
IRS990/NetAssetsOrFundBalancesEOYAmt01998
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0531
IRS990/OfficeExpensesGrp/TotalAmt0531
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt01
IRS990/OtherExpensesGrp/Desc0COMMUNITY OURREACH
IRS990/OtherExpensesGrp/Desc1STORAGE
IRS990/OtherExpensesGrp/Desc2PROFESSIONAL DUES
IRS990/OtherExpensesGrp/Desc3DEVELOPMENT
IRS990/OtherExpensesGrp/FundraisingAmt01500
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt03084
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt11697
IRS990/OtherExpensesGrp/ProgramServicesAmt04500
IRS990/OtherExpensesGrp/TotalAmt04500
IRS990/OtherExpensesGrp/TotalAmt13084
IRS990/OtherExpensesGrp/TotalAmt21697
IRS990/OtherExpensesGrp/TotalAmt31500
IRS990/PartialLiquidationInd00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0KEVIN SLAWIN
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0Investigator-initiated studies: Currently, Dr. Slawin is working on a project involving a family exhibiting an apparent novel, hereditary renal prostate cancer syndrome . The phenotype is inherited in an autosomal dominant pattern. Preliminary analysis suggests that the possible underlying gene defect does not fit the pattern of the known single gene defects that cause known hereditary renal cell carcinoma syndromes or known hereditary prostate cancer. Dr. Slawin has collected tissue and blood samples from the proband including samples of normal tissue, cancer tissues and normal blood, as well as blood samples from other affected and non-affected family members. The following studies on these samples have been initiated: (A) Genomic sequencing using the solid (sequencing by oligonucleotide ligation and detection) system (applied biosystems); (B) Sequence analysis using standard solid analysis software; (C) Array-based comparative genomic hybridization and analysis of the copy-number variants; (D) Analysis of the SNP variants; (E) Segregation analysis; and (F) Use of techniques including but not limited to those listed in A-F to identify the likely genetic alterations causing the phenotype, e.g. hereditary renal and /or prostate cancer or other resultant cancers in this family.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt00
IRS990/ProgSrvcAccomActy2Grp/GrantAmt00
IRS990/ProgSrvcAccomActy2Grp/RevenueAmt00
IRS990/ProgSrvcAccomActy3Grp/Desc0Serum, urine and tissue banking in support of basic molecular urology research: VURF has supported the creation and maintenance of a tissue, urine and serum bank to support urology studies, in particular in the area of diagnosis and treatment of prostate cancer. The human derived biological samples (HDBS) are discarded or "left-over" specimens that have been collected with IRB consent from patients presenting to clinic for prostate evaluation, which may include routine care, or evaluation for BPH , prostatitis, and/or prostate cancer and during an annual prostate cancer screening program conducted by VURF. A state of the art, secure, web-based clinical research database tracks all specimens along with clinical data, providing an invaluable resource for disease marker studies. Utilizing this resource, VURF was able to participate, along with a handful of elite institutions in the country, in a pivotal trial sponsored by Beckman Coulter, testing a new blood test, the "prostate health index" based on the novel molecular form of PSA, 2proPSA, in differentiating patients with prostate cancer from those with benign prostatic pathology and continues to provide support for studies of this new test. VURF is in the process of donating this valuable research resource to University of Texas to support their prostate cancer research program.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt00
IRS990/ProgSrvcAccomActy3Grp/GrantAmt00
IRS990/ProgSrvcAccomActy3Grp/RevenueAmt00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt024000
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt013
IRS990/PYOtherExpensesAmt042901
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-18888
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt042901
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt024013
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt08022
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt00
IRS990ScheduleA/HospitalInd0X
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt00
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt014957
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt014957
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0COPIES OF FORM 990 ARE REVIEWED BY THE PRESIDENT AND DIRECTORS BEFORE FILING.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1UPON REQUEST COPIES ALL APPLICABLE DOCUMENTS ARE FURNISHED. ORGANIZATION IS DEVELOPING A WEBSITE WHICH WILL INCLUDE THESE DOCUMENTS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2GOVERNING DOCUEMNTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE FURNISHED UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3ROUNDING 1.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part VI, Section B, line 11b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part VI, Section C, line 18
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990, Part VI, Section C, line 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Form 990, Part XI, line 9:
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0TX
IRS990/SubjectToProxyTaxInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TempOrPermanentEndowmentsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt01409
IRS990/TotalAssetsEOYAmt02265
IRS990/TotalAssetsGrp/BOYAmt01409
IRS990/TotalAssetsGrp/EOYAmt02265
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt022000
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt01500
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt07984
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt04500
IRS990/TotalFunctionalExpensesGrp/TotalAmt013984
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt07434
IRS990/TotalLiabilitiesEOYAmt0267
IRS990/TotalLiabilitiesGrp/BOYAmt07434
IRS990/TotalLiabilitiesGrp/EOYAmt0267
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0-6025
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt01998
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt04500
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt06
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt022006
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt00
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt01409
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt02265
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UnrestrictedNetAssetsGrp/BOYAmt0-6025
IRS990/UnrestrictedNetAssetsGrp/EOYAmt01998
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt06400 FANNIN ST SUITE 2300
IRS990/USAddress/CityNm0HOUSTON
IRS990/USAddress/StateAbbreviationCd0TX
IRS990/USAddress/ZIPCd077030
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt02
IRS990/WebsiteAddressTxt0n/a
IRS990/WhistleblowerPolicyInd00
ReturnHeader/BuildTS02017-02-10 21:41:12Z
ReturnHeader/BusinessOfficerGrp/PersonNm0KEVIN SLAWIN
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum07132991776
ReturnHeader/BusinessOfficerGrp/SignatureDt02017-11-14
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0VANGUARD UROLOGIC RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0VANG
ReturnHeader/Filer/EIN0205972989
ReturnHeader/Filer/PhoneNum07133667848
ReturnHeader/Filer/USAddress/AddressLine1Txt06400 FANNIN ST No 2300
ReturnHeader/Filer/USAddress/CityNm0HOUSTON
ReturnHeader/Filer/USAddress/StateAbbreviationCd0TX
ReturnHeader/Filer/USAddress/ZIPCd077030
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0DA39A3EE5E6B4B0D3255BFEF95601890AFD80709
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId09FAF11A7A8203FA3F5B04BEDEAE4545EDFA5233E
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt073.32.121.185
ReturnHeader/FilingSecurityInformation/IPDt02017-11-14
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0CS
ReturnHeader/FilingSecurityInformation/IPTm010:38:52
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0741663570
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0SPAIN PRICE READER & THOMPSON PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02727 ALLEN PARKWAY SUITE 1850
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0HOUSTON
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0TX
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd077019
ReturnHeader/PreparerPersonGrp/PhoneNum07135201850
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0RONALD L PRICE
ReturnHeader/ReturnTs02017-11-14T14:33:48-06:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02016-01-01
ReturnHeader/TaxPeriodEndDt02016-12-31
ReturnHeader/TaxYr02016

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2016 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$2,265
Liabilities
$267
Net assets
$1,998
Revenue
$22,006
Expenses
$13,984
Net income
$8,022
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2018Detailed filing. Detailed filing data is available for this year.$0.00$0.00$0.00$0.00$0.28$0.28
2017Detailed filing. Detailed filing data is available for this year.$0.28$0.01$0.28$0.35$0.09$0.26
2016Detailed filing. Detailed filing data is available for this year.$0.02$0.00$0.02$0.22$0.14$0.08
2015Detailed filing. Detailed filing data is available for this year.$0.01$0.07$0.06$0.24$0.43$0.19
2014Summary only. Only limited summary data is available for this year.$0.13$0.00$0.13$0.74$0.66$0.08
2013Summary only. Only limited summary data is available for this year.$0.04$0.00$0.04$2.86$1.93$0.92
2012Summary only. Only limited summary data is available for this year.$0.93$1.81$0.88$4.28$5.72$1.44
2011Summary only. Only limited summary data is available for this year.$0.65$0.08$0.56$8.61$9.04$0.43
2010Summary only. Only limited summary data is available for this year.$1.15$0.15$1.00$6.72$6.51$0.20